ISIN | LU2807512947 |
---|---|
Valor Number | 140384538 |
Bloomberg Global ID | UBMWEAU LX |
Fund Name | UBS (Lux) Fund Solutions - MSCI World ex USA Index Fund UCITS ETF (USD) A-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Asset Allocation |
EFC Category | Equity Global Advanced Markets |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund seeks to broadly track the performance (before costs) of the MSCI World ex USA Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currencyhedged index variant as referred to in relation to each hedged share class below. |
Peculiarities |
Current Price * | 12.56 USD | 03.04.2025 |
---|---|---|
Previous Price * | 12.64 USD | 02.04.2025 |
52 Week High * | 12.97 USD | 18.03.2025 |
52 Week Low * | 12.50 USD | 31.03.2025 |
NAV * | 12.56 USD | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 571,439,450 | |
Unit/Share Assets *** | 15,931,941 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
YTD Performance (in CHF) | - | - |
1 month | -1.51% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 months | -0.88% |
24.02.2025 - 03.04.2025
24.02.2025 03.04.2025 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 1.44% | |
---|---|---|
Nestle SA | 1.38% | |
ASML Holding NV | 1.35% | |
Roche Holding AG | 1.20% | |
AstraZeneca PLC | 1.17% | |
Shell PLC | 1.16% | |
Novartis AG Registered Shares | 1.14% | |
Novo Nordisk AS Class B | 1.14% | |
HSBC Holdings PLC | 1.05% | |
Siemens AG | 0.91% | |
Last data update | 31.03.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.14% |
Ongoing Charges *** | 0.14% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |